annual SGA:
$0.00-$235.78M(-100.00%)Summary
- As of today (September 17, 2025), PCRX annual SGA is $0.00, with the most recent change of -$235.78 million (-100.00%) on December 31, 2024.
- During the last 3 years, PCRX annual SGA has fallen by -$168.46 million (-100.00%).
- PCRX annual SGA is now -100.00% below its all-time high of $235.78 million, reached on December 31, 2023.
Performance
PCRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$88.58M+$1.80M(+2.08%)Summary
- As of today (September 17, 2025), PCRX quarterly SGA is $88.58 million, with the most recent change of +$1.80 million (+2.08%) on June 30, 2025.
- Over the past year, PCRX quarterly SGA has increased by +$20.45 million (+30.02%).
- PCRX quarterly SGA is now at all-time high.
Performance
PCRX quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$836.69M-$127.46M(-17.97%)Summary
- As of today (September 17, 2025), PCRX TTM SGA is -$836.69 million, with the most recent change of -$127.46 million (-17.97%) on June 30, 2025.
- Over the past year, PCRX TTM SGA has dropped by -$1.11 billion (-405.47%).
- PCRX TTM SGA is now -662.27% below its all-time high of -$109.76 million.
Performance
PCRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
PCRX Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | +30.0% | -405.5% |
| 3 y3 years | -100.0% | +36.3% | -464.9% |
| 5 y5 years | -100.0% | +104.4% | -534.7% |
PCRX Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | at high | +44.5% | -101.5% | at low |
| 5 y | 5-year | -100.0% | at low | at high | +104.4% | -101.5% | +47.2% |
| alltime | all time | -100.0% | at low | at high | +8661.4% | -662.3% | +47.2% |
PCRX Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $88.58M(+2.1%) | $329.30M(+6.6%) |
| Mar 2025 | - | $86.78M(+9.0%) | $308.85M(+5.0%) |
| Dec 2024 | $0.00(-100.0%) | $79.61M(+7.1%) | $294.10M(+4.9%) |
| Sep 2024 | - | $74.33M(+9.1%) | $280.29M(+2.3%) |
| Jun 2024 | - | $68.13M(-5.4%) | $273.90M(+1.2%) |
| Mar 2024 | - | $72.03M(+9.5%) | $270.62M(+0.4%) |
| Dec 2023 | $235.78M(+7.7%) | $65.80M(-3.2%) | $269.44M(+0.7%) |
| Sep 2023 | - | $67.95M(+4.8%) | $267.61M(+2.6%) |
| Jun 2023 | - | $64.85M(-8.5%) | $260.95M(-0.1%) |
| Mar 2023 | - | $70.84M(+10.7%) | $261.10M(+2.6%) |
| Dec 2022 | $218.99M(+30.0%) | $63.97M(+4.4%) | $254.52M(+4.9%) |
| Sep 2022 | - | $61.28M(-5.7%) | $242.70M(+5.9%) |
| Jun 2022 | - | $65.00M(+1.2%) | $229.27M(+6.6%) |
| Mar 2022 | - | $64.26M(+23.2%) | $215.08M(+7.9%) |
| Dec 2021 | $168.46M(+2.5%) | $52.15M(+9.0%) | $199.34M(-0.3%) |
| Sep 2021 | - | $47.86M(-5.8%) | $200.02M(-2.3%) |
| Jun 2021 | - | $50.81M(+4.7%) | $204.73M(+3.8%) |
| Mar 2021 | - | $48.52M(-8.2%) | $197.26M(+1.9%) |
| Dec 2020 | $164.40M(-18.1%) | $52.83M(+0.5%) | $193.52M(-0.7%) |
| Sep 2020 | - | $52.56M(+21.3%) | $194.91M(+1.3%) |
| Jun 2020 | - | $43.34M(-3.2%) | $192.47M(-2.9%) |
| Mar 2020 | - | $44.78M(-17.4%) | $198.26M(-1.3%) |
| Dec 2019 | $200.78M(+13.3%) | $54.22M(+8.2%) | $200.78M(+5.0%) |
| Sep 2019 | - | $50.13M(+2.0%) | $191.21M(+3.2%) |
| Jun 2019 | - | $49.13M(+3.8%) | $185.26M(+2.7%) |
| Mar 2019 | - | $47.30M(+6.0%) | $180.38M(+1.8%) |
| Dec 2018 | $177.26M(+9.8%) | $44.65M(+1.1%) | $177.26M(+3.2%) |
| Sep 2018 | - | $44.18M(-0.2%) | $171.80M(+2.1%) |
| Jun 2018 | - | $44.25M(+0.1%) | $168.26M(+2.9%) |
| Mar 2018 | - | $44.19M(+12.8%) | $163.56M(+1.3%) |
| Dec 2017 | $161.49M | $39.18M(-3.6%) | $161.49M(+2.9%) |
| Sep 2017 | - | $40.64M(+2.8%) | $156.99M(+2.8%) |
| Jun 2017 | - | $39.55M(-6.1%) | $152.66M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $42.12M(+21.5%) | $156.78M(+2.7%) |
| Dec 2016 | $152.61M(+9.8%) | $34.67M(-4.5%) | $152.61M(-1.9%) |
| Sep 2016 | - | $36.31M(-16.8%) | $155.49M(+0.6%) |
| Jun 2016 | - | $43.67M(+15.0%) | $154.49M(+6.1%) |
| Mar 2016 | - | $37.96M(+1.1%) | $145.57M(+4.7%) |
| Dec 2015 | $139.04M(+30.4%) | $37.55M(+6.4%) | $139.04M(+4.9%) |
| Sep 2015 | - | $35.31M(+1.6%) | $132.51M(+5.7%) |
| Jun 2015 | - | $34.75M(+10.6%) | $125.42M(+8.6%) |
| Mar 2015 | - | $31.43M(+1.3%) | $115.50M(+8.3%) |
| Dec 2014 | $106.66M(+70.6%) | $31.02M(+9.9%) | $106.66M(+11.3%) |
| Sep 2014 | - | $28.22M(+13.6%) | $95.81M(+15.6%) |
| Jun 2014 | - | $24.84M(+10.0%) | $82.92M(+14.9%) |
| Mar 2014 | - | $22.59M(+12.0%) | $72.16M(+15.4%) |
| Dec 2013 | $62.51M(+35.0%) | $20.17M(+31.7%) | $62.51M(+12.2%) |
| Sep 2013 | - | $15.32M(+8.8%) | $55.70M(+7.6%) |
| Jun 2013 | - | $14.08M(+8.8%) | $51.76M(+7.6%) |
| Mar 2013 | - | $12.94M(-3.2%) | $48.09M(+3.9%) |
| Dec 2012 | $46.31M(+129.7%) | $13.36M(+17.4%) | $46.31M(+15.4%) |
| Sep 2012 | - | $11.38M(+9.3%) | $40.14M(+19.0%) |
| Jun 2012 | - | $10.41M(-6.6%) | $33.74M(+21.4%) |
| Mar 2012 | - | $11.15M(+54.9%) | $27.79M(+37.8%) |
| Dec 2011 | $20.16M(+234.3%) | $7.20M(+44.8%) | $20.16M(+31.1%) |
| Sep 2011 | - | $4.97M(+11.3%) | $15.38M(+27.1%) |
| Jun 2011 | - | $4.47M(+26.8%) | $12.10M(+36.4%) |
| Mar 2011 | - | $3.52M(+45.6%) | $8.87M(+39.5%) |
| Dec 2010 | $6.03M(+20.1%) | $2.42M(+42.8%) | $6.36M(+26.2%) |
| Sep 2010 | - | $1.69M(+36.8%) | $5.04M(+2.1%) |
| Jun 2010 | - | $1.24M(+22.5%) | $4.94M(+33.4%) |
| Mar 2010 | - | $1.01M(-8.1%) | $3.70M(+37.6%) |
| Dec 2009 | $5.02M(-41.7%) | $1.10M(-30.9%) | $2.69M(+69.1%) |
| Sep 2009 | - | $1.59M | $1.59M |
| Dec 2008 | $8.61M(+103.8%) | - | - |
| Dec 2007 | $4.22M | - | - |
FAQ
- What is Pacira BioSciences, Inc. annual SGA?
- What is the all time high annual SGA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. annual SGA year-on-year change?
- What is Pacira BioSciences, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. quarterly SGA year-on-year change?
- What is Pacira BioSciences, Inc. TTM SGA?
- What is the all time high TTM SGA for Pacira BioSciences, Inc.?
- What is Pacira BioSciences, Inc. TTM SGA year-on-year change?
What is Pacira BioSciences, Inc. annual SGA?
The current annual SGA of PCRX is $0.00
What is the all time high annual SGA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high annual SGA is $235.78M
What is Pacira BioSciences, Inc. annual SGA year-on-year change?
Over the past year, PCRX annual SGA has changed by -$235.78M (-100.00%)
What is Pacira BioSciences, Inc. quarterly SGA?
The current quarterly SGA of PCRX is $88.58M
What is the all time high quarterly SGA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high quarterly SGA is $88.58M
What is Pacira BioSciences, Inc. quarterly SGA year-on-year change?
Over the past year, PCRX quarterly SGA has changed by +$20.45M (+30.02%)
What is Pacira BioSciences, Inc. TTM SGA?
The current TTM SGA of PCRX is -$836.69M
What is the all time high TTM SGA for Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. all-time high TTM SGA is -$109.76M
What is Pacira BioSciences, Inc. TTM SGA year-on-year change?
Over the past year, PCRX TTM SGA has changed by -$1.11B (-405.47%)